Log in to save to my catalogue

MLKL-mediated necroptosis is a target for cardiac protection in mouse models of type-1 diabetes

MLKL-mediated necroptosis is a target for cardiac protection in mouse models of type-1 diabetes

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ada2e978445144918d77f081a979c81e

MLKL-mediated necroptosis is a target for cardiac protection in mouse models of type-1 diabetes

About this item

Full title

MLKL-mediated necroptosis is a target for cardiac protection in mouse models of type-1 diabetes

Publisher

London: BioMed Central Ltd

Journal title

Cardiovascular Diabetology, 2022-08, Vol.21 (1), p.1-165, Article 165

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Cardiomyocyte death contributes to cardiac pathology of diabetes. Studies have shown that the RIPK3/MLKL necroptosis signaling is activated in diabetic hearts. Deletion of RIPK3 was reported to attenuate myocardial injury and heart dysfunction in streptozocin (STZ)-induced diabetic mice, suggesting a potential role of necroptosis in diab...

Alternative Titles

Full title

MLKL-mediated necroptosis is a target for cardiac protection in mouse models of type-1 diabetes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ada2e978445144918d77f081a979c81e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ada2e978445144918d77f081a979c81e

Other Identifiers

ISSN

1475-2840

E-ISSN

1475-2840

DOI

10.1186/s12933-022-01602-9

How to access this item